Literature DB >> 25193260

Virtual screening: an in silico tool for interlacing the chemical universe with the proteome.

Yvonne Westermaier1, Xavier Barril2, Leonardo Scapozza3.   

Abstract

In silico screening both in the forward (traditional virtual screening) and reverse sense (inverse virtual screening (IVS)) are helpful techniques for interlacing the chemical universe of small molecules with the proteome. The former, which is using a protein structure and a large chemical database, is well-known by the scientific community. We have chosen here to provide an overview on the latter, focusing on validation and target prioritization strategies. By comparing it to complementary or alternative wet-lab approaches, we put IVS in the broader context of chemical genomics, target discovery and drug design. By giving examples from the literature and an own example on how to validate the approach, we provide guidance on the issues related to IVS.
Copyright © 2014 Elsevier Inc. All rights reserved.

Keywords:  Chemical proteomics; Inverse virtual screening; Molecular docking; Scoring; Target deconvolution; Target discovery; Target prioritization; Validation; Virtual screening

Mesh:

Substances:

Year:  2014        PMID: 25193260     DOI: 10.1016/j.ymeth.2014.08.001

Source DB:  PubMed          Journal:  Methods        ISSN: 1046-2023            Impact factor:   3.608


  16 in total

1.  Docking-based virtual screening of Brazilian natural compounds using the OOMT as the pharmacological target database.

Authors:  Ana Paula Carregal; Flávia V Maciel; Juliano B Carregal; Bianca Dos Reis Santos; Alisson Marques da Silva; Alex G Taranto
Journal:  J Mol Model       Date:  2017-03-11       Impact factor: 1.810

2.  Peptide aptamer identified by molecular docking targeting translationally controlled tumor protein in leukemia cells.

Authors:  Onat Kadioglu; Thomas Efferth
Journal:  Invest New Drugs       Date:  2016-03-14       Impact factor: 3.850

3.  Successful application of virtual screening and molecular dynamics simulations against antimalarial molecular targets.

Authors:  Renata Rachide Nunes; Marina Dos Santos Costa; Bianca Dos Reis Santos; Amanda Luisa da Fonseca; Lorena Sales Ferreira; Rafael Cesar Russo Chagas; Alisson Marques da Silva; Fernando de Pilla Varotti; Alex Gutterres Taranto
Journal:  Mem Inst Oswaldo Cruz       Date:  2016-11-10       Impact factor: 2.743

4.  Homoharringtonine targets Smad3 and TGF-β pathway to inhibit the proliferation of acute myeloid leukemia cells.

Authors:  Jian Chen; Qitian Mu; Xia Li; Xiufeng Yin; Mengxia Yu; Jing Jin; Chenying Li; Yile Zhou; Jiani Zhou; Shanshan Suo; Demin Lu; Jie Jin
Journal:  Oncotarget       Date:  2017-06-20

5.  Identification of Selective Novel Hits against Plasmodium falciparum Prolyl tRNA Synthetase Active Site and a Predicted Allosteric Site Using in silico Approaches.

Authors:  Dorothy Wavinya Nyamai; Özlem Tastan Bishop
Journal:  Int J Mol Sci       Date:  2020-05-27       Impact factor: 5.923

6.  QSAR, molecular docking and ADMET properties in silico studies of novel 4,5,6,7-tetrahydrobenzo[D]-thiazol-2-Yl derivatives derived from dimedone as potent anti-tumor agents through inhibition of C-Met receptor tyrosine kinase.

Authors:  Ossama Daoui; Souad Elkhattabi; Samir Chtita; Rachida Elkhalabi; Hsaine Zgou; Adil Touimi Benjelloun
Journal:  Heliyon       Date:  2021-07-03

7.  Discovery of Novel Human Epidermal Growth Factor Receptor-2 Inhibitors by Structure-based Virtual Screening.

Authors:  Zheng Shi; Tian Yu; Rong Sun; Shan Wang; Xiao-Qian Chen; Li-Jia Cheng; Rong Liu
Journal:  Pharmacogn Mag       Date:  2016 Apr-Jun       Impact factor: 1.085

Review 8.  How 'Protein-Docking' Translates into the New Emerging Field of Docking Small Molecules to Nucleic Acids?

Authors:  Francesca Tessaro; Leonardo Scapozza
Journal:  Molecules       Date:  2020-06-13       Impact factor: 4.411

9.  Discrimination of Naturally-Occurring 2-Arylbenzofurans as Cyclooxygenase-2 Inhibitors: Insights into the Binding Mode and Enzymatic Inhibitory Activity.

Authors:  Ericsson Coy-Barrera
Journal:  Biomolecules       Date:  2020-01-23

10.  Identification of Anti-Mycobacterium and Anti-Legionella Compounds With Potential Distinctive Structural Scaffolds From an HD-PBL Using Phenotypic Screens in Amoebae Host Models.

Authors:  Nabil Hanna; Sébastien Kicka; Gianpaolo Chiriano; Christopher Harrison; Hajer Ouertatani Sakouhi; Valentin Trofimov; Agata Kranjc; Jahn Nitschke; Marco Pagni; Pierre Cosson; Hubert Hilbi; Leonardo Scapozza; Thierry Soldati
Journal:  Front Microbiol       Date:  2020-02-21       Impact factor: 5.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.